Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Alethia BioTherapeutics Inc.
DescriptionAntibody-drug conjugate targeting cell-surface protein KAAG-1
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today